Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,134 | -102,562 | -92,189 | -74,375 | -31,696 |
| Depreciation Amortization | 10,247 | 7,481 | 9,613 | 5,033 | 4,634 |
| Accounts receivable | -6,671 | 4,838 | -2,012 | -6,176 | -1,738 |
| Accounts payable and accrued liabilities | 1,713 | -2,239 | 764 | 3,402 | -716 |
| Other Working Capital | -3,004 | 5,665 | -6,026 | -18,002 | -31,394 |
| Other Operating Activity | 3,537 | 20,387 | 22,332 | 22,189 | 13,021 |
| Operating Cash Flow | $-78,312 | $-66,430 | $-67,518 | $-67,929 | $-47,889 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 64,883 | -36,561 | 8,843 | -6,667 | 16,079 |
| PPE Investments | -2,836 | -1,854 | -10,392 | -8,197 | -2,973 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,500 |
| Investing Cash Flow | $62,047 | $-38,415 | $-1,549 | $-14,864 | $8,606 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,500 | N/A | N/A |
| Common Stock Issued | 8,548 | 107,182 | 73,309 | 65,929 | 36,463 |
| Other Financing Activity | 18,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $26,548 | $107,182 | $68,809 | $65,929 | $36,463 |
| Beginning Cash Position | 23,644 | 21,307 | 21,265 | 33,629 | 36,449 |
| End Cash Position | 33,927 | 23,644 | 21,007 | 16,765 | 33,629 |
| Net Cash Flow | $10,283 | $2,337 | $-258 | $-16,864 | $-2,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,312 | -66,430 | -67,518 | -67,929 | -47,889 |
| Capital Expenditure | -2,836 | -1,854 | -10,433 | -8,207 | -3,009 |
| Free Cash Flow | -81,148 | -68,284 | -77,951 | -76,136 | -50,898 |